• 1. Palladium-catalyzed functionalizations of acidic and non-acidic C(sp3)–H bonds – recent advances
  Gaurav Saini,Manmohan Kapur Chem. Commun. 2021 57 1693
• 2. Pd-catalyzed bidentate auxiliary assisted remote C(sp3)–H functionalization
  Kangkan Talukdar,Tariq A. Shah,Tanumay Sarkar,Subhasish Roy,Prabhat Kumar Maharana,Tharmalingam Punniyamurthy Chem. Commun. 2021 57 13221
• 3. Theoretical study of the 4-pyridylmethyl and the 2- and 5-pyrimidyl-methyl cations and radicals
  Charles U. Pittman,Maurice R. Smith,Gary D. Nichols,Shing K. Wuu,Lowell D. Kispert J. Chem. Soc. Perkin Trans. 2 1975 1581
• 4. Metal carbonyl mediated rearrangement of 5-(2-oxoalkyl)-1,2,4-oxadiazoles: synthesis of fully substituted pyrimidines
  Ekaterina E. Galenko,Timur O. Zanakhov,Mikhail S. Novikov,Alexander F. Khlebnikov Org. Biomol. Chem. 2023 21 2990

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Recent Advances in the Application of 4-Bromopyrimidine (CAS: 31462-56-3) in Chemical Biology and Pharmaceutical Research

4-Bromopyrimidine (CAS: 31462-56-3) is a versatile heterocyclic compound that has garnered significant attention in chemical biology and pharmaceutical research due to its utility as a key building block in drug discovery and development. Recent studies have highlighted its role in the synthesis of novel bioactive molecules, particularly in the context of kinase inhibitors, antiviral agents, and anticancer compounds. This research brief aims to summarize the latest findings and applications of 4-Bromopyrimidine, focusing on its chemical properties, synthetic methodologies, and biological activities.

One of the most notable advancements in the use of 4-Bromopyrimidine is its incorporation into the design of kinase inhibitors. Kinases are critical targets in the treatment of various cancers and inflammatory diseases. Researchers have recently reported the synthesis of potent and selective kinase inhibitors by leveraging the reactivity of the bromine atom in 4-Bromopyrimidine, which allows for efficient cross-coupling reactions. For instance, a study published in the Journal of Medicinal Chemistry demonstrated the successful development of a new class of EGFR inhibitors using 4-Bromopyrimidine as a central scaffold, exhibiting promising antitumor activity in preclinical models.

In addition to its role in kinase inhibitor development, 4-Bromopyrimidine has also been explored as a precursor for antiviral agents. A recent study in Antiviral Research detailed the synthesis of pyrimidine-based nucleoside analogs using 4-Bromopyrimidine, which showed potent activity against RNA viruses, including SARS-CoV-2. The ability to modify the pyrimidine ring at the 4-position provides a strategic advantage in tailoring the pharmacokinetic and pharmacodynamic properties of these compounds, making them attractive candidates for further development.

Beyond its applications in drug discovery, 4-Bromopyrimidine has also been utilized in chemical biology for the development of probes and tools to study biological systems. For example, researchers have employed 4-Bromopyrimidine in the synthesis of fluorescent probes for imaging nucleic acid dynamics in live cells. These probes have enabled real-time visualization of DNA and RNA interactions, offering new insights into cellular processes and potential therapeutic targets.

In conclusion, 4-Bromopyrimidine (CAS: 31462-56-3) continues to be a valuable compound in chemical biology and pharmaceutical research, with recent studies underscoring its versatility and potential in drug discovery and biological tool development. Ongoing research is expected to further expand its applications, particularly in the design of targeted therapies and diagnostic agents. As such, 4-Bromopyrimidine remains a compound of significant interest to researchers in the field.

• 3921-01-5(2,4-Dibromopyrimidine)
• 36847-11-7(2,4,6-Tribromopyrimidine)
• 36847-10-6(4,6-Dibromopyrimidine)
• 1185316-25-9(4-bromo-2-(methyl-d3)pyrimidine)
• 1598222-27-5(4,6-Dibromo-2-methylpyrimidine)
• 1185318-90-4(4-bromopyrimidine-2-d)
• 1187931-22-1(4-Bromopyrimidine hydrobromide)
• 1114560-76-7(4-Bromo-2-methylpyrimidine)
• 343926-69-2(4-bromopyrimidin-2-amine)
• 1255099-57-0(4-Bromopyrimidine HCl)